» Articles » PMID: 29422515

Notch Signaling Regulates Hey2 Expression in a Spatiotemporal Dependent Manner During Cardiac Morphogenesis and Trabecular Specification

Overview
Journal Sci Rep
Specialty Science
Date 2018 Feb 10
PMID 29422515
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hey2 gene mutations in both humans and mice have been associated with multiple cardiac defects. However, the currently reported localization of Hey2 in the ventricular compact zone cannot explain the wide variety of cardiac defects. Furthermore, it was reported that, in contrast to other organs, Notch doesn't regulate Hey2 in the heart. To determine the expression pattern and the regulation of Hey2, we used novel methods including RNAscope and a Hey2 knockin line to precisely determine the spatiotemporal expression pattern and level of Hey2 during cardiac development. We found that Hey2 is expressed in the endocardial cells of the atrioventricular canal and the outflow tract, as well as at the base of trabeculae, in addition to the reported expression in the ventricular compact myocardium. By disrupting several signaling pathways that regulate trabeculation and/or compaction, we found that, in contrast to previous reports, Notch signaling and Nrg1/ErbB2 regulate Hey2 expression level in myocardium and/or endocardium, but not its expression pattern: weak expression in trabecular myocardium and strong expression in compact myocardium. Instead, we found that FGF signaling regulates the expression pattern of Hey2 in the early myocardium, and regulates the expression level of Hey2 in a Notch1 dependent manner.

Citing Articles

The transcriptional repressor HEY2 regulates mitochondrial oxidative respiration to maintain cardiac homeostasis.

She P, Gao B, Li D, Wu C, Zhu X, He Y Nat Commun. 2025; 16(1):232.

PMID: 39747914 PMC: 11696871. DOI: 10.1038/s41467-024-55557-4.


Development of the Cardiac Conduction System.

van der Maarel L, Christoffels V Adv Exp Med Biol. 2024; 1441:185-200.

PMID: 38884712 DOI: 10.1007/978-3-031-44087-8_10.


β1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation.

Miao L, Lu Y, Nusrat A, Zhao L, Castillo M, Xiao Y Cardiovasc Res. 2024; 120(11):1279-1294.

PMID: 38794925 PMC: 11416060. DOI: 10.1093/cvr/cvae111.


Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead.

Datta S, Cao W, Skillman M, Wu M Int J Mol Sci. 2023; 24(20).

PMID: 37894928 PMC: 10607600. DOI: 10.3390/ijms242015249.


Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.

Fetisov T, Borunova A, Antipova A, Antoshina E, Trukhanova L, Gorkova T Biomedicines. 2023; 11(1).

PMID: 36672738 PMC: 9856019. DOI: 10.3390/biomedicines11010230.


References
1.
Kokubo H, Tomita-Miyagawa S, Hamada Y, Saga Y . Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development. 2007; 134(4):747-55. DOI: 10.1242/dev.02777. View

2.
Xin M, Kim Y, Sutherland L, Qi X, McAnally J, Schwartz R . Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal. 2011; 4(196):ra70. PMC: 3440872. DOI: 10.1126/scisignal.2002278. View

3.
Leimeister C, Dale K, Fischer A, Klamt B, Hrabe de Angelis M, Radtke F . Oscillating expression of c-Hey2 in the presomitic mesoderm suggests that the segmentation clock may use combinatorial signaling through multiple interacting bHLH factors. Dev Biol. 2000; 227(1):91-103. DOI: 10.1006/dbio.2000.9884. View

4.
Hartman M, Liu Y, Zhu W, Chien W, Weldy C, Fishman G . Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias. FASEB J. 2014; 28(7):3007-15. PMC: 4062830. DOI: 10.1096/fj.14-251728. View

5.
Bezzina C, Barc J, Mizusawa Y, Remme C, Gourraud J, Simonet F . Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet. 2013; 45(9):1044-9. PMC: 3869788. DOI: 10.1038/ng.2712. View